Turn off MathJax
Article Contents
MingYuan Liu, Meili Wang, JunjunLiu, AnQiang Sun, ChangShun He, Xin Cong, Wei Kong, Wei Li. Hemodynamic Disturbance and mTORC1 Activation: Unveiling the Biomechanical Pathogenesis of Thoracic Aortic Aneurysms in Marfan Syndrome[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2024.101120
Citation: MingYuan Liu, Meili Wang, JunjunLiu, AnQiang Sun, ChangShun He, Xin Cong, Wei Kong, Wei Li. Hemodynamic Disturbance and mTORC1 Activation: Unveiling the Biomechanical Pathogenesis of Thoracic Aortic Aneurysms in Marfan Syndrome[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2024.101120

Hemodynamic Disturbance and mTORC1 Activation: Unveiling the Biomechanical Pathogenesis of Thoracic Aortic Aneurysms in Marfan Syndrome

doi: 10.1016/j.jpha.2024.101120
Funds:

This work was supported by the National Natural Science Foundations of China (82000429 and 81470574), Young Elite Scientists Sponsorship Program by CAST (No.YESS20230395/2023QNRC001), Beijing Nova Program (No.20230484308), Youth Elite Program of Beijing Friendship Hospital (YYQCJH2022-9), Young Elite Scientists Sponsorship Program by BAST (No.BYESS2024045), Capital’s Funds for Health Improvement and Research (CFH2022-4-20217), and Chinese Institutes for Medical Research, Beijing (CIMR) Organized Research Project (No.CX23YQ07).

  • Received Date: Mar. 27, 2024
  • Accepted Date: Oct. 10, 2024
  • Rev Recd Date: Sep. 19, 2024
  • Available Online: Oct. 30, 2024
  • Thoracic aortic aneurysm (TAA) significantly endangers the lives of individuals with Marfan syndrome (MFS), yet the intricacies of their biomechanical origins remain elusive. Our investigation delves into the pivotal role of hemodynamic disturbance in the pathogenesis of TAA, with a particular emphasis on the mechanistic contributions of the mammalian target of rapamycin (mTOR) signaling cascade. We uncovered that activation of the mTOR complex 1 (mTORC1) within smooth muscle cells, instigated by the oscillatory wall shear stress (OSS) that stems from disturbed flow (DF), is a catalyst for TAA progression. This revelation was corroborated through both an MFS mouse model (Fbn1+/C1039G) and clinical MFS specimens. Crucially, our research demonstrates a direct linkage between the activation of the mTORC1 pathway and the intensity in OSS. Therapeutic administration of rapamycin suppresses mTORC1 activity, leading to the attenuation of aberrant SMC behavior, reduced inflammatory infiltration, and restoration of extracellular matrix integrity—collectively decelerating TAA advancement in our mouse model. These insights posit the mTORC1 axis as a strategic target for intervention, offering a novel approach to manage TAAs in MFS and potentially pave insights for current treatment paradigms.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (21) PDF downloads(0) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return